Loading data
APVONasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | 3.11 m USD | 12.29 m USD |
| Research and development expense | 14.54 m USD | 14.38 m USD | 17.11 m USD | 17.88 m USD | 18.99 m USD |
| Operating profit | -26.31 m USD | -24.6 m USD | -28.88 m USD | -28.64 m USD | -21.4 m USD |
| Profit before tax | -25.97 m USD | -24.13 m USD | -18.65 m USD | 7.01 m USD | -29.41 m USD |
| Income tax expense | 0 USD | — | — | — | — |
| Net income (reported basis) | -25.97 m USD | -24.13 m USD | -17.41 m USD | 8.03 m USD | -28.46 m USD |
| Net income attributable to common shareholders | -27.54 m USD | -24.13 m USD | — | — | — |
| Basic earnings per share | -87.27 USD/share | -31,460.23 USD/share | -2,316.83 USD/share | 1.57 USD/share | -6.07 USD/share |
| Diluted earnings per share | -87.27 USD/share | -31,460.23 USD/share | -2,316.83 USD/share | 1.57 USD/share | -6.07 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.